Access cutting-edge pediatric lymphoma treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access pediatric lymphoma specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric lymphoma treatment provided free
The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin lymphoma (MB-NHL) and classical Hodgkin lymphoma (cHL).
Sponsor: New York Medical College
Check if you qualify for this pediatric lymphoma clinical trial in Birmingham, AL
If you're searching for pediatric lymphoma treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.